Windtree Therapeutics has missed EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, Windtree Therapeutics has averaged an EPS surprise of 2.32% and a revenue surprise of 0.00%.
Analyze the earnings history of Windtree Therapeutics using advanced sorting and filters.
The chart below shows Windtree Therapeutics's reported EPS compared to analyst estimates over recent quarters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2024-04-17 | $-855.00 | $-846.00 | -1.06 % |
| Q3 | 2023-11-09 | $-774.00 | $-567.00 | -36.5 % |
| Q2 | 2023-08-07 | $-1.48K | $-612.00 | -141.2 % |
| Q1 | 2023-05-15 | $-4.28K | $-504.00 | -750.0 % |
The chart below shows Windtree Therapeutics's reported revenue compared to analyst estimates over recent quarters.
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2023-04-03 | $0 | $100.00K | -100.0 % |
Windtree Therapeutics (WINT) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 19, 2025 for Q3.
Windtree Therapeutics (WINT) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 19, 2025 for Q3 and the Actual EPS was $-1.08, which missed the estimate of $0.00.
Windtree Therapeutics (WINT) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 19, 2025 for Q3 and the Actual Revenue was $0.00, which hit the estimate of $0.00.